Optimized Outcome Prediction in Breast Cancer by Combining the 70-Gene Signature with Clinical Risk Prediction Algorithms

PUBLICATION: Breast Cancer Res Treat. 2014 Jun;145(3):697-705. doi: 10.1007/s10549-014-2954-2. Epub Read More

2024-03-25T10:21:40-07:00June 1st, 2014|Adjuvant, Evidence, MammaPrint, RASTER|

Risk Estimations and Treatment Decisions in Early Stage Breast Cancer: Agreement Among Oncologists and the Impact of the 70-Gene Signature

PUBLICATION: Eur J Cancer. 2014 Apr;50(6):1045-54. doi: 10.1016/j.ejca.2014.01.016. Epub 2014 Read More

2024-03-25T10:23:07-07:00April 1st, 2014|Adjuvant, Evidence, MammaPrint, RASTER|

A Prospective Evaluation of a Breast Cancer Prognosis Signature in the Observational RASTER Study

PUBLICATION: Int J Cancer. 2013 Aug 15;133(4):929-36. doi: 10.1002/ijc.28082. Epub Read More

2024-03-25T10:47:48-07:00January 13th, 2013|Adjuvant, Evidence, MammaPrint, RASTER|

Use of 70-gene Signature to Predict Prognosis of Patients with Node-Negative Breast Cancer: A Prospective Community-Based Feasibility Study (RASTER)

PUBLICATION:  Lancet Oncol. 2007 Dec;8(12):1079-1087. doi: 10.1016/S1470-2045(07)70346-7. Epub 2007 Nov Read More

2024-03-07T10:58:08-08:00December 8th, 2007|Adjuvant, Evidence, MammaPrint, RASTER|
Go to Top